Announcement on Foreign Investment by Wholly-owned Subsidiary
Filed with SSE · · 6 pages · Chinese
Beijing Konruns Pharmaceutical Co., Ltd. on 6ix
Earlier from Beijing Konruns Pharmaceutical
- Announcement on Risk Warning of Stock Trading
- Announcement on Obtaining Notice of Clinical Trial for Project KC1086
- Announcement on Resolution of the 14th Meeting of the 4th Board of Supervisors
Later from Beijing Konruns Pharmaceutical
- Announcement on Resolutions of the 18th Meeting of the 4th Board of Directors
- Announcement on Completion of the First Subject Enrollment in the Phase 1 Clinical Trial of KC1086
- Announcement on Resolutions of the 15th Meeting of the 4th Board of Supervisors
- Announcement on Lifting Sales Restrictions in the 1st Sales Restriction Period of Reserved Grant under the 2023 Restricted Stock Incentive Plan and Listing of Shares
- Announcement on Abnormal Fluctuations in Stock Trading
Follow Beijing Konruns Pharmaceutical into a list and get an email when it puts out news.
Follow Beijing Konruns Pharmaceutical